Neurology Devices Market Size, Growth and Forecast 2034
Neurology Devices Market Growth, Size, Trends Analysis- By Product - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Oct-2025 | Report ID: MEDE2565 | Pages: 1 - 258 | Formats*: |
| Category : Medical Devices | |||
Neurology Devices Market Introduction and Overview
According to SPER Market Research, the Global Neurology Devices Market is estimated to reach USD 30.79 billion by 2034 with a CAGR 9.15%.
The report includes an in-depth analysis of the Global Neurology Devices Market, including market size and trends, product mix, Applications, and supplier analysis. The global Neurology Devices Market was valued at USD 12.83 billion in 2024 and is expected to grow at a CAGR of over 9.15% from 2025 to 2034. The growing prevalence of neurological disorders like Alzheimer's, Parkinson's, and epilepsy is driving demand for advanced neurology devices. Technological innovations in neurostimulation—such as adaptive deep brain stimulation, vagus nerve stimulation, and transcranial magnetic stimulation—are enhancing treatment outcomes and boosting market growth. Additionally, the rise of home healthcare and remote patient monitoring is increasing the need for portable EEGs, home-based neurostimulation, and wearable devices. These tools support continuous care for chronic conditions, promote patient independence, and reduce the burden on healthcare systems by minimizing hospital stays.
By Product:
The neurostimulation segment leads the market, with spinal cord stimulation devices at the forefront, widely used for managing chronic back pain and related conditions. Their dominance stems from proven effectiveness in pain relief and quality-of-life improvement. Technological advancements continue to drive growth by enhancing the precision, accessibility, and personalization of therapies. Innovations such as miniaturized implants, wireless systems, rechargeable and battery-free neurostimulators, and non-invasive techniques like transcranial magnetic stimulation are expanding patient access. These developments underscore the increasing adoption of neuromodulation devices in treating chronic pain and neurological disorders.
Regional Insights:
North America leads the global neurology devices market, driven by a high prevalence of neurological disorders and a well-established healthcare infrastructure. Strong investment in research and development fosters ongoing innovation, while an aging population and favorable reimbursement policies support continued growth. The presence of major industry players also reinforces the region’s dominance. Meanwhile, the Asia Pacific market is projected to grow rapidly, fueled by rising healthcare spending and increasing neurological cases. Expanding healthcare infrastructure, growing awareness of early diagnosis, and the introduction of advanced products are accelerating adoption across countries like China and India.
Market Competitive Landscape:
The Neurology Devices Market is highly consolidated. Some of the market key players are Abbott, Acandis GmbH, Axonics, Inc., Boston Scientific Corporation, Brain lab AG, Codman Neuro (Integra Lifesciences), CooperSurgical Inc., electroCore, Inc., Johnson and Johnson Services Inc., LivaNova PLC, Medtronic, Microport Scientific Corporation, Microvention Inc (Terumo Corporation), Neuropace Inc.
Recent Developments:
In February 2025, Medtronic received U.S. FDA approval for the world’s first Adaptive Deep Brain Stimulation (DBS) system designed for individuals with Parkinson’s disease. This innovative technology adjusts stimulation levels in real time by responding to the patient’s brain signals, enabling a more personalized and responsive treatment experience.
In February 2025, the University Hospitals of Geneva (HUG), the Department of Health and Mobility (DSM) of the Canton of Geneva, and the Wyss Center for Bio and Neuroengineering announced the creation of an artificial intelligence (AI) hub dedicated to healthcare and neuromodulation. Set to open in the second half of 2025 at Campus Biotech, the 1,000 m² facility will focus on advancing the treatment and prevention of neurological and psychiatric disorders.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Product |
| Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa |
| Companies Covered | Abbott, Acandis GmbH, Axonics, Inc., Boston Scientific Corporation, Brain lab AG, Codman Neuro (Integra Lifesciences), CooperSurgical Inc., electroCore, Inc., Johnson and Johnson Services Inc., LivaNova PLC, Medtronic, Microport Scientific Corporation, Microvention Inc (Terumo Corporation), Neuropace Inc. |
- Global Neurology Devices Market Size (FY 2021-FY 2034)
- Overview of Global Neurology Devices Market
- Segmentation of Global Neurology Devices Market By Product (Neurostimulation, Interventional Neurology, CSF Management Devices, Neurosurgery Devices)
- Statistical Snap of Global Neurology Devices Market
- Expansion Analysis of Global Neurology Devices Market
- Problems and Obstacles in Global Neurology Devices Market
- Competitive Landscape in the Global Neurology Devices Market
- Details on Current Investment in Global Neurology Devices Market
- Competitive Analysis of Global Neurology Devices Market
- Prominent Players in the Global Neurology Devices Market
- SWOT Analysis of Global Neurology Devices Market
- Global Neurology Devices Market Future Outlook and Projections (FY 2025-FY 2034)
- Recommendations from Analyst
1. Introduction
- 1.1. Scope of the report
- 1.2. Market segment analysis
2. Research Methodology
- 2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPERs internal database
- 2.1.4. Premium insight from KOLs
- 2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
- 2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
- 4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
5. Market variable and outlook
- 5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
- 5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
- 5.3. PORTERs Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
- 5.4. Heat Map Analysis
6. Competitive Landscape
- 6.1. Global Neurology Devices Market Manufacturing Base Distribution, Sales Area, Product Type
- 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Neurology Devices Market
7. Global Neurology Devices Market, By Product, (USD Million) 2021-2034
- 7.1. Neurostimulation
- 7.1.1. Spinal Cord Stimulation
- 7.1.2. Spinal Cord Stimulation
- 7.1.3. Deep Brain Stimulation
- 7.1.4. Sacral Nerve Stimulation
- 7.1.5. Vagus Nerve Stimulation
- 7.1.6. Gastric Electric Stimulation
- 7.2. Interventional Neurology
- 7.2.1. Aneurysm Coiling and Embolization
- 7.2.2. Neurovascular Catheters
- 7.2.3. Cerebral Balloon Angioplasty &Stents
- 7.2.4. Neurothromobectomy
- 7.3. CSF Management Devices
- 7.3.1. Cerebral Shunts
- 7.3.2. Cerebral External Drainage
- 7.4. Neurosurgery Devices
- 7.4.1. Ultrasonic Aspirators
- 7.4.2. Stereotactic Systems
- 7.4.3. Neuroendoscopes
- 7.4.4. Aneurysm Clips
8. Global Neurology Devices Market, (USD Million) 2021-2034
- 8.1. Global Neurology Devices Market Size and Market Share
9. Global Neurology Devices Market, By Region, 2021-2034 (USD Million)
- 9.1. Asia-Pacific
- 9.1.1. Australia
- 9.1.2. China
- 9.1.3. India
- 9.1.4. Japan
- 9.1.5. South Korea
- 9.1.6. Rest of Asia-Pacific
- 9.2. Europe
- 9.2.1. France
- 9.2.2. Germany
- 9.2.3. Italy
- 9.2.4. Spain
- 9.2.5. United Kingdom
- 9.2.6. Rest of Europe
- 9.3. Middle East and Africa
- 9.3.1. Kingdom of Saudi Arabia
- 9.3.2. United Arab Emirates
- 9.3.3. Qatar
- 9.3.4. South Africa
- 9.3.5. Egypt
- 9.3.6. Morocco
- 9.3.7. Nigeria
- 9.3.8. Rest of Middle-East and Africa
- 9.4. North America
- 9.4.1. Canada
- 9.4.2. Mexico
- 9.4.3. United States
- 9.5. Latin America
- 9.5.1. Argentina
- 9.5.2. Brazil
- 9.5.3. Rest of Latin America
10. Company Profile
- 10.1. Abbott
- 10.1.1. Company details
- 10.1.2. Financial outlook
- 10.1.3. Product summary
- 10.1.4. Recent developments
- 10.2. Acandis GmbH
- 10.2.1. Company details
- 10.2.2. Financial outlook
- 10.2.3. Product summary
- 10.2.4. Recent developments
- 10.3. Axonics, Inc.
- 10.3.1. Company details
- 10.3.2. Financial outlook
- 10.3.3. Product summary
- 10.3.4. Recent developments
- 10.4. Boston Scientific Corporation
- 10.4.1. Company details
- 10.4.2. Financial outlook
- 10.4.3. Product summary
- 10.4.4. Recent developments
- 10.5. Brain lab AG
- 10.5.1. Company details
- 10.5.2. Financial outlook
- 10.5.3. Product summary
- 10.5.4. Recent developments
- 10.6. Codman Neuro (Integra Lifesciences)
- 10.6.1. Company details
- 10.6.2. Financial outlook
- 10.6.3. Product summary
- 10.6.4. Recent developments
- 10.7. CooperSurgical Inc.
- 10.7.1. Company details
- 10.7.2. Financial outlook
- 10.7.3. Product summary
- 10.7.4. Recent developments
- 10.8. electroCore, Inc.
- 10.8.1. Company details
- 10.8.2. Financial outlook
- 10.8.3. Product summary
- 10.8.4. Recent developments
- 10.9. Johnson and Johnson Services Inc.
- 10.9.1. Company details
- 10.9.2. Financial outlook
- 10.9.3. Product summary
- 10.9.4. Recent developments
- 10.10. LivaNova PLC
- 10.10.1. Company details
- 10.10.2. Financial outlook
- 10.10.3. Product summary
- 10.10.4. Recent developments
- 10.11. Medtronic
- 10.11.1. Company details
- 10.11.2. Financial outlook
- 10.11.3. Product summary
- 10.11.4. Recent developments
- 10.12. Microport Scientific Corporation
- 10.12.1. Company details
- 10.12.2. Financial outlook
- 10.12.3. Product summary
- 10.12.4. Recent developments
- 10.13. Microvention Inc (Terumo Corporation)
- 10.13.1. Company details
- 10.13.2. Financial outlook
- 10.13.3. Product summary
- 10.13.4. Recent developments
- 10.14. Neuropace Inc.
- 10.14.1. Company details
- 10.14.2. Financial outlook
- 10.14.3. Product summary
- 10.14.4. Recent developments
- 10.15. Others
11. Conclusion
12. List of Abbreviations
13. Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Neurology Devices Market is covered By Product
Neurology Devices Market is projected to reach USD 30.79 billion by 2034, growing at a CAGR of of 9.15% during the forecast period.
Neurology Devices Market grew in Market size from 2025. The Market is expected to reach USD 30.79 billion by 2034, at a CAGR of 9.15 billion% during the forecast period.
Neurology Devices Market CAGR of 9.15% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Neurology Devices Market size is USD 30.79 billion from 2025 to 2034.
The North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa is the highest Market share in the Neurology Devices Market.
Abbott, Acandis GmbH, Axonics, Inc., Boston Scientific Corporation, Brain lab AG, Codman Neuro (Integra Lifesciences), CooperSurgical Inc., electroCore, Inc., Johnson and Johnson Services Inc., LivaNova PLC, Medtronic, Microport Scientific Corporation, Microvention Inc (Terumo Corporation), Neuropace Inc.
The report includes an in-depth analysis of the Global Neurology Devices Market, including market size and trends, product mix, Applications, and supplier analysis.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
